Fidaxomicin Favored Over Vancomycin in Real-World C diff Study
Researchers compared the agents for treating both initial and recurrent Clostridioides difficile infections in a Medicare population.
Source: medscape.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Dubberke. Real-time updates on events, politics, business and more.